Progression and remission of nephropathy in type 2 diabetes: new strategies of treatment and monitoring.
Rossing
Kasper
K
Steno Diabetes Centre, Gentofte. karo@steno.dk
D000419:Albuminuria / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D000959:Antihypertensive Agents / Q000627:therapeutic use; D015415:Biomarkers / Q000378:metabolism; D003924:Diabetes Mellitus, Type 2 / Q000150:complications*; D003928:Diabetic Nephropathies / Q000175:diagnosis / Q000209:etiology* / Q000378:metabolism / Q000628:therapy*; D018450:Disease Progression; D050171:Dyslipidemias / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D006801:Humans; D006943:Hyperglycemia / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D006977:Hypertension, Renal / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D011379:Prognosis; D040901:Proteomics / Q000379:methods; D012074:Remission Induction / Q000379:methods; D012084:Renin-Angiotensin System / Q000187:drug effects; D012307:Risk Factors
D000959:Antihypertensive Agents; D015415:Biomarkers